![](/images/graphics-bg.png)
Biomarkers of Cervical Dysplasia and Carcinoma
Joint Authors
Hwang, Sonya J.
Shroyer, Kenneth R.
Source
Issue
Vol. 2012, Issue 2012 (31 Dec. 2012), pp.1-9, 9 p.
Publisher
Hindawi Publishing Corporation
Publication Date
2011-10-29
Country of Publication
Egypt
No. of Pages
9
Main Subjects
Abstract EN
Although cervical cytology screening has decreased the incidence of cervical cancer in industrialized countries, HPV-related cervical disease, including premalignant and malignant lesions, continues to represent a major burden on the health care system.
Some of the problems include the potential for either under- or overtreatment of women due to decreased specificity of screening tests as well as significant interobserver variability in the diagnosis of cervical dysplastic lesions.
Although not completely elucidated, the HPV-driven molecular mechanisms underlying the development of cervical lesions have provided a number of potential biomarkers for both diagnostic and prognostic use in the clinical management of these women.
American Psychological Association (APA)
Hwang, Sonya J.& Shroyer, Kenneth R.. 2011. Biomarkers of Cervical Dysplasia and Carcinoma. Journal of Oncology،Vol. 2012, no. 2012, pp.1-9.
https://search.emarefa.net/detail/BIM-477128
Modern Language Association (MLA)
Hwang, Sonya J.& Shroyer, Kenneth R.. Biomarkers of Cervical Dysplasia and Carcinoma. Journal of Oncology No. 2012 (2012), pp.1-9.
https://search.emarefa.net/detail/BIM-477128
American Medical Association (AMA)
Hwang, Sonya J.& Shroyer, Kenneth R.. Biomarkers of Cervical Dysplasia and Carcinoma. Journal of Oncology. 2011. Vol. 2012, no. 2012, pp.1-9.
https://search.emarefa.net/detail/BIM-477128
Data Type
Journal Articles
Language
English
Notes
Includes bibliographical references
Record ID
BIM-477128